To: The Honorable Mitch McConnell, The Honorable Chuck Schumer, The Honorable Nancy Pelosi, The Honorable Kevin McCarthy
"As Congress considers its end-of-the-year priorities, the undersigned organizations representing patients, providers, and taxpayers strongly encourage you to enact this bipartisan fix to encourage greater adoption and use of lower-cost biosimilar medicines. We believe this modest proposal – which the Congressional Budget Office scored as revenue neutral6 – would move us closer to fulfilling the promise of biosimilars and helping millions of patients who live with chronic conditions."
Read the Full Letter
We rely on your voice to advocate for our policy priorities. Join us to show our strength as a community that cares about endocrinology. Contact your U.S representatives or European Members of Parliament through our online platform. Take action and make a difference today.